Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma - Zimmer, Lisa; Utikal, Jochen; Schadendorf, Dirk (European journal of cancer, 2017)
Gesehen am 17.08.2018